Trade Mark Journal No.2025/045 7 November 2025

WO0000001881962 (5)

Office of origin: United States of America

Date of International Registration:22 September 2025
Date of designation in the UK: 22 September 2025
Image for mark 1881962 AMBIVAX

International priority date claimed: 21 March 2025 (United States of America) (99096430)
Class 5
Medicinal preparations; biological preparations; pharmaceutical preparations; vaccines; immune boosters being medicinal preparations and pharmaceutical preparations; all of the aforementioned containing any of messenger RNA, an adenovirus vector, or a yeast vector; and all of the aforementioned for use in the treatment and/or prevention of cancer and infectious diseases.

ImmunityBio, Inc.

Representative: Alicia M. Passerin Leech Tishman Fuscaldo & Lampl, 525 William Penn Place, 28th Floor, Pittsburgh PA 15219, UNITED STATES OF AMERICA